Next Article in Journal
Evaluation of the Safety, Tolerability and Immunogenicity of ShigETEC, an Oral Live Attenuated Shigella-ETEC Vaccine in Placebo-Controlled Randomized Phase 1 Trial
Previous Article in Journal
Four Faces of Cell-Surface HLA Class-I: Their Antigenic and Immunogenic Divergence Generating Novel Targets for Vaccines
 
 
Article

Article Versions Notes

Vaccines 2022, 10(2), 338; https://doi.org/10.3390/vaccines10020338
Action Date Notes Link
article xml file uploaded 21 February 2022 10:15 CET Original file -
article xml uploaded. 21 February 2022 10:15 CET Update -
article pdf uploaded. 21 February 2022 10:15 CET Version of Record -
article supplementary file uploaded. 21 February 2022 10:15 CET - https://www.mdpi.com/2076-393X/10/2/338#supplementary
article html file updated 21 February 2022 10:17 CET Original file -
article xml file uploaded 21 February 2022 10:17 CET Update -
article xml uploaded. 21 February 2022 10:17 CET Update https://www.mdpi.com/2076-393X/10/2/338/xml
article pdf uploaded. 21 February 2022 10:17 CET Updated version of record https://www.mdpi.com/2076-393X/10/2/338/pdf
article html file updated 21 February 2022 10:18 CET Update -
article html file updated 1 August 2022 01:24 CEST Update https://www.mdpi.com/2076-393X/10/2/338/html
Back to TopTop